The immunohistochemical staining process has undergone significant changes over the past decade. The introduction of an automated staining system has reduced the average processing time per slide from 90 minutes to 35 minutes, with an efficiency increase of over 60%. Take Roche Diagnostics’ BenchMark ULTRA as an example. This device can process up to 30 slides in a single run, support simultaneous staining of up to 20 different antibodies, and increase the throughput by approximately 300%. After the pathology department of a certain tertiary hospital adopted the automated immunohistochemistry stainer, the daily sample processing volume increased from 40 cases to 100 cases, and the report issuance time was compressed from 72 hours to within 24 hours. This efficiency improvement directly reduces labor costs. Laboratory personnel can cut their operation time by 30% and devote more energy to result interpretation and complex case analysis.
Standardization is the core advantage of automated dyeing machines. Studies have shown that the batch-to-batch variation coefficient of manual staining results can be as high as 15-20%, while the use of automated systems such as Leica BOND-MAX can control the coefficient of variation within 5%. By precisely controlling the antibody incubation temperature (37±0.5℃) and reaction time (with an error of ±5 seconds), the repeatability of the staining results was significantly improved. A multicenter study conducted by the American College of Pathologists in 2019 showed that automated systems increased the compliance rate of immunohistochemical quality control from 82% to 97% and reduced the incidence of false negative results to less than 3%. This standardized characteristic is particularly important for the detection of key biomarkers such as HER2 and PD-L1, directly affecting the accuracy of targeted treatment regimens.
In terms of cost control, the automated system achieves significant savings by optimizing the usage of reagents. The intelligent droplet dispensing technology reduces the antibody usage per slide from 150μl to 50μl, achieving a reagent saving rate of 66%. If the laboratory processes an average of 200 slides per day, it can save approximately 150,000 US dollars in antibody procurement costs annually. Meanwhile, the integrated waste liquid treatment system has reduced the generation of hazardous chemical waste by 40%, lowering the cost of waste treatment. The lifespan of the equipment is usually 7 to 10 years, and the average annual maintenance cost accounts for about 5 to 8% of the equipment price, which is much lower than the continuous expenditure on one-time consumables required for manual dyeing.
Technological innovation continuously drives the optimization of work processes. The latest generation of staining equipment integrates artificial intelligence pre-analysis functions. For instance, the VENTANA DP600 system can automatically identify tissue areas and optimize antibody titration positions, reducing the staining failure rate from 8% in traditional methods to 1.5%. A multi-center clinical trial reported in Nature Medicine in 2023 showed that a staining system using machine learning algorithms increased the detection sensitivity of weakly positive samples by 22%, which is particularly helpful for the detection of low-expression targets. These technological advancements have enabled laboratories to further reduce the sample turnover time to 18 hours while maintaining an accuracy rate of over 95%, thus buying precious diagnostic time for cancer patients.